Analysts Set Prime Medicine, Inc. (NYSE:PRME) Price Target at $10.08
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight analysts that are currently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation […]
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight analysts that are currently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation […]
